May 30, 2015

Miami-Dade Business Profile

Biscayne Pharmaceuticals

| 8/14/2013
Samuel Reich and Andrew Schally (sitting)
Samuel Reich (standing) and Andrew Schally

For more than half a century, Nobel Prize-winning scientist and University of Miami faculty member Andrew Schally has been researching the hormones that stimulate growth in the body’s tissues. Now his work is being used by Miami-based Biscayne Pharmaceuticals, which was founded last year and licensed from UM the rights to Schally’s inventions related to that research. The company, which Schally works with as scientific adviser, is using his discovery to develop possible treatments for cancer and heart disease.

Biscayne Pharma got going after a $1.5-million investment from its co-founders and Miami Beach investment firm Reich Group, whose Managing Partner Samuel Reich joined Biscayne Pharma as CEO. “This is a breakthrough that will really transform the way we treat cancer,” Reich says.

Tags: Miami-Dade, Healthcare, Technology/Innovation

Digital Access

DIRECT DIGITAL ACCESS
Add digital to your current subscription, purchase a single digital issue, or start a new subscription to Florida Trend.

TABLE OF CONTENTS
An overview of the features and articles in this month's issue of Florida Trend.

ACCESS THIS ISSUE »

Florida Business News

Florida Trend Video Pick

Atlantic Canyons: Pathways to the Abyss
Atlantic Canyons: Pathways to the Abyss

Pathways to the Abyss showcases deepwater marine habitats of two mid-Atlantic Canyons located 100 miles offshore.

Earlier Videos | Viewpoints@FloridaTrend

Ballot Box

Are you OK with opening oil drilling off both Florida coasts?

  • Yes
  • Yes, but only as long as drilling would stay 50 miles offshore
  • No, we should keep the current ban of at least 125 miles offshore in place

See Results

Ballot Box
Subscribe